NORWALK, Conn.–(BUSINESS WIRE)–The Multiple Myeloma Research Foundation (MMRF) today announced four
appointments to its governing board and executive team. The appointees
will work with long-standing MMRF leadership team, who have played a
critical role in advancing the foundation’s end-to-end precision
Giusti has been named President and Chief Executive Officer of the
MMRF. Mr. Giusti, who most recently served as Chief Executive Officer of
Structural Graphics, an integrated marketing firm, has more than 30
years of experience as a business leader and entrepreneur. He has worked
closely with the MMRF on a number of initiatives, most recently chairing
the foundation’s $100 million capital campaign.
Miani has been named Chief Financial Officer of the MMRF. Mr. Miani
most recently served as Vice President of Finance and Corporate
Controller of Aptuit, LLC, a global clinical contract research
organization where he focused on applying business models to scientific
initiatives. He brings to the MMRF more than 20 years of operating
experience in both the private and public sectors.
Mortimer, Executive Partner and Founder of Global Healthcare
Opportunities, LLP, a healthcare investment advisory firm, has been
named Chairman of the MMRF Board of Directors. Mr. Mortimer has more
than 25 years of global operating and management experience, most
recently at Quintiles, where he served as Executive Vice President.
Marcus, founder of Courtyard Connections, a consumer goods advisory
firm, has been named Vice Chairwoman of the MMRF Board of Directors. Ms.
Marcus has more than 30 years of marketing expertise, formerly serving
as Chief Global Brand and Product Officer at Keurig Green Mountain and
Senior Vice President of Marketing Activation for PepsiCo.
MMRF co-founder Kathy
Giusti, a preeminent leader in cancer research, will continue to
serve as a member of the MMRF Board of Directors and as an active
spokesperson and relationship steward for the foundation. Ms. Giusti
will also continue her work as a proponent of patient-centered research
and open-access data sharing.
“We are excited to expand the depth and breadth of the MMRF leadership
team during such a transformative time, one in which science,
technology, and the patient community are uniting toward a shared
goal—to accelerate the research and development of next-generation,
precision treatments and, ultimately, to find a cure,” said Ms. Giusti.
About the Multiple Myeloma Research Foundation
The Multiple Myeloma Research Foundation (MMRF) was established in 1998
as a 501(c) (3) non-profit organization by twin sisters Karen Andrews
and Kathy Giusti, soon after Kathy’s diagnosis with multiple myeloma.
The mission of the MMRF is to relentlessly pursue innovative means that
accelerate the development of next-generation multiple myeloma
treatments to extend the lives of patients and lead to a cure. As the
world’s number-one private funder of multiple myeloma research, the MMRF
has raised more than $300 million since its inception and directs nearly
90% of its total budget to research and related programming. As a
result, the MMRF has been awarded Charity Navigator’s coveted four-star
rating for 12 years, the highest designation for outstanding fiscal
responsibility and exceptional efficiency.
Kathy Giusti, 203-652-0201